In yesterday’s Wall Street session, CVS Health Corp (NYSE:CVS) shares traded at $67.18, down -0.22% from the previous session.
CVS stock price is now -9.87% away from the 50-day moving average and -7.60% away from the 200-day moving average. The market capitalization of the company currently stands at $84.54B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $78, Barclays recently initiated with Equal Weight rating for CVS Health Corp (NYSE: CVS). On February 26, 2024, Leerink Partners recently initiated its ‘Outperform’ rating on the stock quoting a target price of $88, while ‘HSBC Securities’ rates the stock as ‘Buy’
In other news, Shah Prem S, EVP and Pres-Pharm, Consumer W sold 29,473 shares of the company’s stock on Feb 16 ’24. The stock was sold for $2,267,947 at an average price of $76.95. Upon completion of the transaction, the EVP and Pres-Pharm, Consumer W now directly owns 39,765 shares in the company, valued at $2.67 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 03 ’23, Director LUDWIG EDWARD J bought 2,000 shares of the business’s stock. A total of $140,930 was incurred on buying the stock at an average price of $70.47. This leaves the insider owning 20,630 shares of the company worth $1.39 million. A total of 0.19% of the company’s stock is owned by insiders.
During the past 12 months, CVS Health Corp has had a low of $64.41 and a high of $83.25. As of last week, the company has a debt-to-equity ratio of 1.04, a current ratio of 0.86, and a quick ratio of 0.63.
The net profit margin was 2.33% and return on equity was 11.32% for CVS. The company reported revenue of $93.81 billion for the quarter, compared to $83.85 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.89 percent.
